borderline significancep = 0.045
sociated with FGF-21 (excepts CRP, Fibrinogen and IL-6) and again in further fully-adjusted model 3 (model 2 + CRP, Fibrinogen and IL-6); furthermore, non-linearly for FGF-21 ≥ 80.0 mg/dL FGF-21 level to CVD endpoints significantly associated with hard CVD in model 1 (HR:1.34, 95% CI:1.12–1.60) and borderline significance in model 2 (HR:1.20, 95% CI:1.00–1.45) besides hard CHD in model 1 (HR:1.46, 95% CI:1.19–1.80) and model 2 (HR:1.26, p = 0.045) yet in model 3 no significant association was observed for both end-points.